Same Indication

Ipilimumab vs Sumatriptan

Ipilimumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between Ipilimumab and Sumatriptan.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Sumatriptan: Selective 5-HT1B/1D receptor agonist.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Sumatriptan β€” 2.5 hours.

Chemical Properties

Molecular Formula: Sumatriptan β€” C14H21N3O2S.

Molecular Weight: Sumatriptan β€” 295.4020 g/mol.

Type: Ipilimumab β€” Antibody; Sumatriptan β€” Small molecule.